Role of Treatment Cost on Transmission of Multidrug-Resistant Tuberculosis Into Iran

Clinical Infectious Diseases - United Kingdom
doi 10.1093/cid/civ459
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Transmission of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in a Metropolitan City

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

Reducing Harm in the Treatment of Multidrug-Resistant Tuberculosis

The Lancet
Medicine
2018English

Bedaquiline: New Approach for Treatment of Multidrug-Resistant Tuberculosis

RUHS Journal of Health Science
2019English

Impact of Diabetes Mellitus on Treatment Outcome of Multidrug Resistant Pulmonary Tuberculosis

Journal of Evolution of Medical and Dental Sciences
2018English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Recurrence After Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy